EE9900457A - Trovafloksatsiini vesiniksoolade valmistamise protsess - Google Patents

Trovafloksatsiini vesiniksoolade valmistamise protsess

Info

Publication number
EE9900457A
EE9900457A EEP199900457A EEP9900457A EE9900457A EE 9900457 A EE9900457 A EE 9900457A EE P199900457 A EEP199900457 A EE P199900457A EE P9900457 A EEP9900457 A EE P9900457A EE 9900457 A EE9900457 A EE 9900457A
Authority
EE
Estonia
Prior art keywords
trovafloxacin
preparation
hydrogen salts
salts
hydrogen
Prior art date
Application number
EEP199900457A
Other languages
English (en)
Inventor
Norris Timothy
Robert Rose Peter
Michael Devries Keith
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE9900457A publication Critical patent/EE9900457A/et
Publication of EE04118B1 publication Critical patent/EE04118B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
EEP199900457A 1998-09-03 1999-09-02 Trovafloksatsiini vesiniksoolad ja nende valmistamise protsess EE04118B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (2)

Publication Number Publication Date
EE9900457A true EE9900457A (et) 2000-04-17
EE04118B1 EE04118B1 (et) 2003-08-15

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900457A EE04118B1 (et) 1998-09-03 1999-09-02 Trovafloksatsiini vesiniksoolad ja nende valmistamise protsess

Country Status (40)

Country Link
US (1) US6359137B1 (et)
EP (1) EP0989119A1 (et)
JP (1) JP3354526B2 (et)
KR (1) KR20000022858A (et)
CN (1) CN1248580A (et)
AP (1) AP1118A (et)
AR (1) AR021475A1 (et)
AU (1) AU761035B2 (et)
BG (1) BG103703A (et)
BR (1) BR9904082A (et)
CA (1) CA2281244C (et)
CO (1) CO5251466A1 (et)
EA (1) EA002340B1 (et)
EE (1) EE04118B1 (et)
GE (1) GEP20022785B (et)
GT (1) GT199900142A (et)
HN (1) HN1999000141A (et)
HR (1) HRP990274A2 (et)
HU (1) HUP9902967A3 (et)
ID (1) ID23718A (et)
IL (1) IL131614A0 (et)
IN (1) IN191583B (et)
IS (1) IS5168A (et)
MA (1) MA24966A1 (et)
MY (1) MY130800A (et)
NO (1) NO994261L (et)
NZ (1) NZ337605A (et)
OA (1) OA11152A (et)
PA (1) PA8481001A1 (et)
PE (1) PE20001026A1 (et)
PL (1) PL335246A1 (et)
SG (1) SG74748A1 (et)
SK (1) SK116599A3 (et)
SV (1) SV1999000144A (et)
TN (1) TNSN99164A1 (et)
TR (1) TR199902138A2 (et)
TW (1) TW520369B (et)
UY (1) UY25686A1 (et)
YU (1) YU43199A (et)
ZA (1) ZA995630B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CZ286896B6 (en) * 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
DK0789697T3 (da) * 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas

Also Published As

Publication number Publication date
ID23718A (id) 2000-05-11
PL335246A1 (en) 2000-03-13
NO994261D0 (no) 1999-09-02
GEP20022785B (en) 2002-09-25
GT199900142A (es) 2001-02-15
EE04118B1 (et) 2003-08-15
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
HU9902967D0 (en) 1999-10-28
CO5251466A1 (es) 2003-02-28
HRP990274A2 (en) 2000-10-31
EP0989119A1 (en) 2000-03-29
EA002340B1 (ru) 2002-04-25
TR199902138A2 (xx) 2000-04-21
AP1118A (en) 2002-11-21
BG103703A (bg) 2001-08-31
CA2281244A1 (en) 2000-03-03
HUP9902967A2 (hu) 2000-05-28
YU43199A (sh) 2002-11-15
NO994261L (no) 2000-03-06
JP3354526B2 (ja) 2002-12-09
EA199900708A2 (ru) 2000-04-24
AU4482699A (en) 2000-03-16
BR9904082A (pt) 2000-09-12
PA8481001A1 (es) 2000-09-29
AR021475A1 (es) 2002-07-24
AP9901667A0 (en) 1999-12-31
UY25686A1 (es) 2000-03-31
IN191583B (et) 2003-12-06
HN1999000141A (es) 2000-06-19
EA199900708A3 (ru) 2000-08-28
SV1999000144A (es) 2000-09-05
MA24966A1 (fr) 2000-04-01
AU761035B2 (en) 2003-05-29
IL131614A0 (en) 2001-01-28
ZA995630B (en) 2001-03-01
IS5168A (is) 2000-03-04
HUP9902967A3 (en) 2000-11-28
CA2281244C (en) 2003-05-20
PE20001026A1 (es) 2000-10-11
SG74748A1 (en) 2000-08-22
SK116599A3 (en) 2000-05-16
TW520369B (en) 2003-02-11
TNSN99164A1 (fr) 2005-11-10
CN1248580A (zh) 2000-03-29
MY130800A (en) 2007-07-31
JP2000086658A (ja) 2000-03-28
NZ337605A (en) 2001-03-30
US6359137B1 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
HUP0200402A3 (en) An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine
DK1008577T3 (da) Fremgangsmåde til fremstilling af methanol
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
IT1298535B1 (it) Procedimento per la produzione di gamma-butirrolattone
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
FR2818979B1 (fr) Procede de preparation d'imidaclopride
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
NO995851L (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
EE9900457A (et) Trovafloksatsiini vesiniksoolade valmistamise protsess
FR2791669B1 (fr) Procede de preparation du fluoroformiate de tertiobutyle
DK1035098T3 (da) Fremgangsmåde til fremstilling af sorbinsyre
NO20005148D0 (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
IL128611A0 (en) Process for the preparation of substituted pyridines
NO20013453D0 (no) Fremgangsmåte for fremstilling av salter av cyanobenzylaminer
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral
FI981465A0 (fi) Biokatalyyttinen menetelmä aldehydien valmistamiseksi
ITMI992459A0 (it) Procedimento per la preparazione di marbofloxacina
DK1071674T3 (da) Fremgangsmåde til fremstilling af chlorbenzoxazoler
IT1308677B1 (it) Procedimento per produrre 2,2,6,6-tetrametil-4-piperidone

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20040902